An important strategy for improving the antitumor selectivity and decreasing severe side effect of antitumor agents is to design carrier systems and prodrugs.Here, we review the most important prodrug models based on doxorubicin.
No takes yet. Share an insight, caveat, or question.
Rollas et al. (2008) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: